Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: Three-month comparison of efficacy and safety

Current Medical Research and Opinion

Volumn 20, Issue 9, 2004, Pages 1333-1339

  Martinez De La Casa, J M ^a,b   Castillo, A ^a   Garcia Feijoo, J ^a   Mendez Hernandez, C ^a   Fernandez Vidal, A ^a   Garcia Sanchez, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b NONE   (Spain)

Author keywords

Brinzolamide; Fixed combination; Glaucoma; Latanoprost; Timolol; Travoprost

Indexed keywords

BRINZOLAMIDE; LATANOPROST; LATANOPROST PLUS TIMOLOL; TIMOLOL; TRAVOPROST; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERABILITY; EYE BURNING; EYE PAIN; EYE STINGING; FEMALE; FIXED COMBINATION THERAPY; HUMAN; HYPEREMIA; INTRACRANIAL HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; TASTE PERVERSION; VISUAL IMPAIRMENT;

CLOPROSTENOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; SULFONAMIDES; THIAZINES; TIMOLOL;

EID: 5444241192     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125004529     Document Type: Article

References (17)

1. Stewart WC, Stewart JA, Day D, Sharpe ED. Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily. Acta Ophthalmol Scand 2003;81:242-6
2. Pfeiffer N; European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol 2002;240:893-9
3. Higginbotham EJ, Feldman R, Stiles M, Dubiner H; Fixed Combination Investigative Group. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. Arch Ophthalmol 2002;120:915-22
4. Larsson LI. Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. J Glaucoma. 2001;10:109-14
5. O'Connor DJ, Martone JF, Mead A. Additive intraocular pressure lowering effect of various medications with latanoprost. Am J Ophthalmol 2002;133:836-7
6. Garcia-Sanchez J, Xalacom Study Group. Efficacy and safety of the fixed combination latanoprost/timolol versus the hnfixed combination brimonidine/timolol in patients with elevated intraocular pressure: a 6-month, masked-evaluator study. Invest Ophthalmol Vis Sci 2003;44:S2198
7. Rulo AH, Greve EL, Hoyng PF. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. Ophthalmology 1997;104:1503-7
8. Kimal Arici M, Topalkara A, Guler C. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure. Int Ophthalmol 1998;22:37-42
9. Parrish RK, Palmberg P, Sheu WP; XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688-703
10. Dubiner HB, Sircy MD, Landry T, et al. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clin Ther 2004;26:84-91
11. Netland PA, Landry T, Sullivan EK, et al; Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472-84
12. Ingram CJ, Brubaker RF. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes. Am J Ophthalmol 1999;128:292-6
13. Silver LH, the Brinzolamide Comfort Study Group. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution. Results from two multicenter comfort studies. Surv Ophthalmol 2000, 44:141-5
14. McCannel CA, Heinrich SR, Brubaker RF. Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans. Graefes Arch Clin Exp Ophthalmol 1992;230:518-20
15. Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology 1995;102:1743-52
16. Konstas AG, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC. A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol. Am J Ophthalmol 2002;133:753-7
17. Diestelhorst M, Almegard B. Comparison of two fixed combinations of latanoprost and timolol in open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 1998;236:577-81